Activating and inhibitory Fcγ receptors in rheumatoid arthritis: From treatment to targeted therapies

Joel A.G. Van Roon*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Abstract

Fcγ receptors (FcγRs) bind the constant Fc region of IgG molecules. IgG/antigen-containing immune complexes elicit a variety of effector functions in cells that express activating FcγRs. Because activating FcγRs are present on cells from the innate immune system, such as dendritic cells, monocytes/macrophages and granulocytes, these IgG receptors form a crucial link between the innate and the acquired immune systems. Recently, the ability to detect the inhibitory FcγRIIb on cells has indicated an imbalance between activating and inhibitory FcγRs in rheumatoid arthritis. This progress offers an opportunity to study modulation of FcγR balance and could stimulate development of FcγR-directed immunotherapy.

Original languageEnglish
Article number106
JournalArthritis Research and Therapy
Volume9
Issue number4
DOIs
Publication statusPublished - 20 Aug 2007

Fingerprint

Dive into the research topics of 'Activating and inhibitory Fcγ receptors in rheumatoid arthritis: From treatment to targeted therapies'. Together they form a unique fingerprint.

Cite this